Slovakia: Recommended vaccinations
  General recommendation
  Recommendation for specific groups only
  Catch-up (e.g. if previous doses missed)
 
Vaccination not funded by the National Health system
 
Mandatory vaccination
BirthWeeksMonthsYears
62345610111214-15174512131415
tuberculosis
BCG3
diphtheria
D
D
D
D
d
tetanus
TT
TT
TT
TT
TT
pertussis
acP
acP
acP
acP
acP
poliomyelitis
IPV
IPV
IPV
IPV
IPV
Haemophilus influenzae type b infection
Hib
Hib
Hib
hepatitis B1
HepB4
HepB
HepB
HepB
pneumococcal disease1
PCV10 or PCV13 or PCV15
PCV10 or PCV13 or PCV15
PCV10 or PCV13 or PCV155
meningococcal disease
MenB
MenB
MCV4/MenB
MCV4/MenB6
measles
MEAS
MEAS
mumps
MUMPS
MUMPS
rubella
RUBE
RUBE
human papillomavirus infection
HPV9 (F/M)
HPV9 (F/M)
influenza2
IIV4/LAIV7

Version:


Footnotes:

  1. Vaccination is free of charge also for at-risk groups based on national legislation.
  2. Flu vaccine is mandatory for at-risk groups based on national legislation.
  3. Free of charge only for children in defined at-risk groups.
  4. Babies born to a mother infected with hepatitis B will be offered a first dose at birth simultaneously with HB immunoglobulin, and two additional doses: one at 1 month and one at 6 months
  5. https://www.ockovaniechrani.sk/#/ockovaci-kalendar
  6. One dose of each vaccine if given between 14 and 15 years
  7. Vaccination against influenza is supported by the legislation for children 6 months – 12 years, individuals with specified chronic medical conditions, older adults aged 59 years and above and people accommodated in long-term facilities. However, the vaccination is generally recommended and fully funded to the whole population in every influenza season.


More information available at:
https://www.ockovaniechrani.sk/ https://szu.cz/tema/vakciny-a-ockovani/


-------------------------------------------------------------------------------------------------------------------------------

MAJOR HISTORICAL CHANGES

Measles, mumps and rubella:
1969: Measles vaccine introduced into national childhood vaccination schedule for children aged 12 months
1974: Age for measles vaccination changed to 9 months
1977: Second dose of measles vaccine was introduced to 11 - 15 months old children
1982: Age of measles vaccination changed to 11 months for the first dose and to 18 - 22 months for the second dose. Rubella vaccination was introduced for 11 year- old seronegative girls
1984: Rubella vaccination was introduced for all 11 years old girls
1985: Age of measles vaccination changed to 14 months for the first dose and to 20 - 24 months for the second dose. Rubella vaccination was introduced for all 2 years old children
1987: Combined mumps and measles vaccine introduced into national childhood vaccination schedule at 14 months (first dose) and 20-24 months (second dose)
1990: Second dose vaccination against mumps and measles changed to 13 years
1992: Combined vaccine against measles, mumps and rubella was introduced into national childhood vaccination in schedule 14 months (first dose) and 13 years (second dose)
1995: Age of second MMR dose changed to 10 years
2020: Age of second MMR dose changed to 4 years.

Hepatitis B:
1998: HepB introduced
2004: HepB is given at 10 years of age
2008: Vaccination completed in ex-adolescents

Haemophilus influenza type b:
2000: Hib introduced

HPV:
2020: Gender-neutral (boys and girls) HPV vaccination offered free of charge

Poliomyelitis:
2005: IPV replaced OPV

Diphtheria and tetanus:
2004: Booster dose of Td introduced for children 12 years of age
2009: Booster dose introduced for adults every 15 years after the previous vaccination

Pertussis:
2010: July. Re-vaccination in 12 years old children with tetravalent vaccine dTap-IPV was implemented into the national childhood vaccination schedule replacing the trivalent vaccine dT-IPV.

Pneumococcal vaccine:
2008: April. PCV7 universally recommended to children less than 2 years old as complementary (optional) vaccination for optimal individual protection. Cost of vaccine is shared with 96% of cost reimbursed by the national health insurance. However, it is free of charge to children less than 2 years old belonging to risk groups
2009: January. PCV7 implemented into the national vaccination schedule as compulsory being fully reimbursed by the national health insurance
2010: July. PCV13 implemeted into the national childhood vaccination schedule replacing PCV7
2011: Two vaccines, PCV13 and PCV10, were decided to be used for mandatory vaccination

Tuberculossis:
2010: July. Re-vaccination of 10 year-old tuberculin-negative children was withdrawn from the national childhood vaccination schedule
2012: January. Vaccination of newborns against tuberculosis was cancelled



VACCINES RECOMMENDED FOR AT-RISK GROUPS:
HEALTHCARE WORKERS:
-- Tuberculosis (only tuberculin negative HCW before appointing to the Department of Tuberculosis and Respiratory Infections and Pathology, microbiologists and vets at high risk of infection)
-- Hepatitis B (HCW at high risk of infection, students of medical schools)
-- Hepatitis A (paediatricians, GPs, infectious disease specialists and gastroenterologists, employees of laboratories at high risk of infection)
-- Influenza (HCW in direct contact with patients)

BABIES/CHILDREN:
-- Hepatitis B (babies of HBsAg positive mothers, children placed in centers for drug addicted persons)
-- Hepatitis A (2 years old children living in poor hygienic conditions)
-- Influenza (children from 6th months up to 12 years)
-- HPV (for 12 years old girls and boys)

ELDERLY:
-- Hepatitis B (persons living in social care facilities for mentally ill people)
-- Influenza (persons in social care facilities, persons in the age of 59 years and older)
-- Pneumococcal disease (persons in social care facilities, persons in the age of 59 years and older)

PEOPLE REGARDLESS OF AGE WITH UNDERLYING CONDITIONS:
--Influenza(persons with serious chronic diseases of respiratory and cardiovascular system, with metabolic, renal disorders and disorders of immunity)
-- Ppneumococcal disease (persons with serious chronic diseases of respiratory and cardiovascular system, with metabolic, renal disorders and disorders of immunity)
-- Hepatitis B (persons with chronic disease of liver, diabetics, persons with cystic fibrosis)
-- Hepatitis A (persons with chronic disease of liver)

-------------------------------------------------------------------------------------------------------------------------------

Date of last update: 22 Jan. 2024

-------------------------------------------------------------------------------------------------------------------------------